Importer of Controlled Substances Application: R & D Systems, Inc., 35546-35547 [2017-16064]
Download as PDF
<![CDATA[
35546
Federal Register / Vol. 82, No. 145 / Monday, July 31, 2017 / Notices
personal identifying information in your
comment, you should be aware that
your entire comment, including your
personal identifying information, may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Authority: The authorities for this action
are the Surface Mining Control and
Reclamation Act of 1977, as amended (30
U.S.C. 1201 et seq.), and the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501 et
seq.).
Dated: June 15, 2017.
John A. Trelease,
Acting Chief, Division of Regulatory Support.
[FR Doc. 2017–16044 Filed 7–28–17; 8:45 am]
BILLING CODE 4310–05–P
DEPARTMENT OF JUSTICE
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Chrysler Group, LLC,
Auburn Hills, MI, and Mercedes-Benz
Research & Development North
America, Inc., Sunnyvale, CA, have
withdrawn as a parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and V2I
Consortium intends to file additional
written notifications disclosing all
changes in membership.
On December 3, 2014, V2I Consortium
filed its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on December 31, 2014
(79 FR 78908).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
Antitrust Division
Notice Pursuant to the National
Cooper, Ative Research and
Production Act of 1993—Vehicle To
Infrastructure Consortium
[FR Doc. 2017–16050 Filed 7–28–17; 8:45 am]
BILLING CODE P
Notice is hereby given that, on June
29, 2017, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Vehicle to
Infrastructure Consortium (‘‘V2I
Consortium’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Isosciences,
LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before September 29, 2017.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on May 17,
2017, Isosciences, LLC, 1017 West 9th
Avenue, Building 10, Suite B, King of
Prussia, Pennsylvania 19406 applied to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
sradovich on DSKBCFCHB2PROD with NOTICES
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .......................................................................................................................
Amphetamine ...................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Codeine ...........................................................................................................................................................................
Morphine ..........................................................................................................................................................................
The company plans to manufacture
small quantities of the listed controlled
substances to make reference standards
which will be distributed to their
customers.
Dated: July 24, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–16060 Filed 7–28–17; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
17:38 Jul 28, 2017
Jkt 241001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: R & D Systems, Inc.
ACTION:
Notice of application.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
I
I
I
I
I
II
II
II
II
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before August 30, 2017. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before August 30,
2017.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
ADDRESSES:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
DATES:
1235
1237
7315
7400
7404
1100
1105
9050
9300
Schedule
E:\FR\FM\31JYN1.SGM
31JYN1
35547
Federal Register / Vol. 82, No. 145 / Monday, July 31, 2017 / Notices
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
SUPPLEMENTARY INFORMATION:
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on March
7, 2017, R & D Systems, Inc., BioTechne, 614 McKinley Place NE.,
Minneapolis, Minnesota 55413 applied
to be registered as an importer of the
following basic classes of controlled
substances:
Controlled substance
Drug code
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..............................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .............................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
Psilocyn ...........................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Cocaine ............................................................................................................................................................................
The company plans to import bulk
active pharmaceutical controlled
substances for distribution to its
customers for analytical purposes.
In reference to drug codes 7360 and
7370, the company plans to import a
synthetic cannabidiol and a synthetic
tetrahydrocannabinol. No other activity
for these drug codes is authorized for
this registration.
Dated: July 24, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–16064 Filed 7–28–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Sigma-Aldrich
International GMBH
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
sradovich on DSKBCFCHB2PROD with NOTICES
DATES:
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before August 30, 2017. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before August 30,
2017.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
ADDRESSES:
Drug code
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
N-Ethylamphetamine .......................................................................................................................................................
Aminorex ..........................................................................................................................................................................
Gamma Hydroxybutyric Acid ...........................................................................................................................................
17:38 Jul 28, 2017
Jkt 241001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
II
II
II
material are not appropriate. 72 FR
3417, (January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix of subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on January
19, 2016, Sigma-Aldrich International
GMBH, Sigma Aldrich Co. LLC, 3500
Dekalb Street, Saint Louis, Missouri
63118 applied to be registered as an
importer of the following basic classes
of controlled substances:
Controlled substance
VerDate Sep<11>2014
1248
7118
7297
7360
7370
7391
7405
7435
7438
2270
7471
9041
Schedule
E:\FR\FM\31JYN1.SGM
31JYN1
1235
1237
1248
1475
1585
2010
Schedule
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 82, Number 145 (Monday, July 31, 2017)]
[Notices]
[Pages 35546-35547]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16064]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: R & D Systems,
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before August 30, 2017. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before August 30, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701
[[Page 35547]]
Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on March
7, 2017, R & D Systems, Inc., Bio-Techne, 614 McKinley Place NE.,
Minneapolis, Minnesota 55413 applied to be registered as an importer of
the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
JWH-018 (also known as AM678) (1- 7118 I
Pentyl-3-(1-naphthoyl)indole).
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-
phenol).
Marihuana.......................... 7360 I
Tetrahydrocannabinols.............. 7370 I
4-Bromo-2,5-dimethoxyamphetamine... 7391 I
3,4-Methylenedioxymethamphetamine.. 7405 I
Dimethyltryptamine................. 7435 I
Psilocyn........................... 7438 I
Pentobarbital...................... 2270 II
Phencyclidine...................... 7471 II
Cocaine............................ 9041 II
------------------------------------------------------------------------
The company plans to import bulk active pharmaceutical controlled
substances for distribution to its customers for analytical purposes.
In reference to drug codes 7360 and 7370, the company plans to
import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No
other activity for these drug codes is authorized for this
registration.
Dated: July 24, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-16064 Filed 7-28-17; 8:45 am]
BILLING CODE 4410-09-P
